TOV-21G（人卵巢癌細(xì)胞）
CBP60292
詢(xún) 價(jià)
索取STR
產(chǎn)品描述
產(chǎn)品數(shù)據(jù)庫(kù)
| I. General information | |
| Synonyms: | TOV-21G |
| Background: | This cell line was initiated in October of 1991 from a patient of French-Canadian descent with no family history of ovarian cancer. |
| Species: | Homo sapiens, human |
| Tissue: | ovary |
| Disease: | grade 3, stage III,primary malignant adenocarcinoma; clear cell carcinoma |
| Gender: | female, 62 years, |
| Morphology: | epithelial |
| Growth Mode: | adherent |
| DNA Profile: | Amelogenin: X CSF1PO: 13,15 D13S317: 11,12 D16S539: 10,12 D5S818: 12,13 D7S820: 12 THO1: 7,9.3 TPOX: 8,11 vWA: 17 Our Cell Line Authentication Service |
| Culture Medium: |
1:1 mixture of MCDB 105 medium and Medium 199,85%; FBS,15% TOV-21G完全培養(yǎng)基，# CBP60292M |
| Cryopreservation medium: | 90%FBS+10%DMSO |
| Oncogene: | p53 + (wild type) |
| Genes Expressed: | keratin |
| Cellular Products: | keratin |
| Tumor Formation: | Yes, form colonies in soft agar Yes, the cells are tumorigenic in nude mice |
| Comments: | Like OV-90 (ATCC CRL-11732), the OV-21G (ATCC CRL-11730) cell line exhibits a deletion at chromosome 3p24. The TOV-112D (ATCC CRL-11731) cell line does not exhibit a deletion at chromosome 3p24. For more information, please contact us (4008-750-250). |
